CASK activators constitute a diverse array of compounds that intricately modulate CASK activation through direct or indirect mechanisms. These chemicals, with distinct modes of action, provide valuable insights into the regulatory pathways governing CASK activation. Among the direct activators, A23187 and Ionophore Ionomycin play pivotal roles by inducing calcium influx, directly binding to CASK and triggering conformational changes that enhance its catalytic activity. Forskolin, a cyclic AMP elevating agent, indirectly activates CASK by stimulating adenylate cyclase, leading to increased cAMP levels and subsequent activation of CASK through intricate signaling cascades. Furthermore, PKC activators like PMA and PDBu indirectly modulate CASK activation by influencing the PKC pathway, where CASK interacts with PKC. These compounds stimulate PKC, leading to downstream effects that activate CASK through intricate signaling cascades.
Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activators, represented by FPL 64176, indirectly influence CASK activation by modulating calcium homeostasis. This compound enhances CASK activation through increased calcium uptake into the endoplasmic reticulum, leading to elevated cytosolic calcium levels and subsequent CASK activation through direct binding. In summary, CASK activators represent a diverse class of compounds that intricately modulate CASK activation through direct binding, elevation of cAMP levels, or modulation of calcium homeostasis. These compounds provide valuable insights into the regulatory networks governing CASK activation and offer potential avenues for further exploration in understanding cellular signaling dynamics.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, indirectly activates CASK by elevating cAMP levels. CASK is linked to cAMP signaling, and Forskolin stimulates adenylate cyclase, leading to increased cAMP production. This elevated cAMP, in turn, activates CASK through intricate signaling cascades. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a protein kinase C (PKC) activator, indirectly modulates CASK by activating the PKC pathway. CASK interacts with PKC, and PMA stimulates PKC, leading to downstream effects that influence CASK activation through the modulation of PKC-dependent signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionophore Ionomycin, similar to A23187, directly activates CASK by facilitating calcium influx. The elevated intracellular calcium levels induced by Ionomycin directly bind to CASK, resulting in conformational changes and subsequent activation of the protein. | ||||||
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt | 30275-80-0 | sc-300167 | 10 µmol | $324.00 | 1 | |
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt directly influences CASK activation by mimicking the effects of cAMP. This compound activates CASK by binding to its cAMP-binding domains, inducing conformational changes that lead to increased enzymatic activity and modulation of downstream signaling pathways associated with CASK activation. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin-1, a PKC modulator, indirectly activates CASK by influencing the PKC pathway. CASK interacts with PKC, and Bryostatin-1 modulates PKC activity, leading to downstream effects that activate CASK through intricate signaling cascades. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin, also known as A23187, directly activates CASK by promoting calcium influx. CASK, being calcium-dependent, undergoes activation upon binding to elevated intracellular calcium levels induced by Calcimycin, triggering conformational changes that enhance its catalytic activity and downstream signaling pathways. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176, a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator, indirectly influences CASK activation by modulating calcium homeostasis. CASK activation is facilitated by FPL 64176 through increased calcium uptake into the endoplasmic reticulum, leading to elevated cytosolic calcium levels and subsequent CASK activation through direct binding. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
OAG, a diacylglycerol analog, indirectly activates CASK by modulating the diacylglycerol pathway. CASK interacts with components of this pathway, and OAG stimulates diacylglycerol production, leading to downstream effects that influence CASK activation through the modulation of diacylglycerol-dependent signaling pathways. | ||||||
8-CPT-cAMP | 93882-12-3 | sc-201569 sc-201569A | 20 mg 100 mg | $87.00 $316.00 | 19 | |
8-CPT-cAMP, a cyclic AMP analog, directly influences CASK activation by mimicking the effects of cAMP. This compound activates CASK by binding to its cAMP-binding domains, inducing conformational changes that lead to increased enzymatic activity and modulation of downstream signaling pathways associated with CASK activation. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
PDBu, a PKC activator, indirectly modulates CASK activation by stimulating the PKC pathway. CASK interacts with PKC, and PDBu activates PKC, leading to downstream effects that influence CASK activation through intricate signaling cascades. | ||||||